Nanocarrier-based topical drug delivery for the treatment of skin diseases

被引:181
作者
Gupta, Madhu [1 ]
Agrawal, Udita [1 ]
Vyas, Suresh P. [1 ,2 ]
机构
[1] Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar, MP, India
[2] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar 470003, MP, India
关键词
nanocarriers; skin; skin disorders; topical delivery; SOLID LIPID NANOPARTICLES; IN-VITRO; DERMAL DELIVERY; PERMEATION ENHANCEMENT; LIPOSOME ENCAPSULATION; DEFORMABLE LIPOSOMES; PENETRATION ENHANCER; CYPROTERONE-ACETATE; CARRIERS; VESICLES;
D O I
10.1517/17425247.2012.686490
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Skin disorders will continue to cause complications in patients. At present, there is an expansion of research into dermatologic treatment due to a critical need for new treatment options to treat skin diseases. Areas covered: The skin itself provides a natural barrier against particle penetration for topical delivery. However, it also offers a potential approach for the delivery of therapeutics, especially in diseased skin and via the openings of hair follicles. Recent innovation might be achieved in the field of dermatological treatment with improvement in the dermal localization of bioactives into the affected skin region, via novel nanocarriers that deliver the drugs directly to the target cells. After application, these nanocarriers can penetrate through the stratum corneum into viable skin and accumulate at the target site. However, noteworthy uptake does occur after damage and in certain diseased skin. Expert opinion: Skin-targeted topical delivery by means of nanosystems, in order to produce sustained release and maintain a localized effect, will result in an effective treatment of various life-threatening dermatological conditions. In addition, research continues into the interactions between novel particles, skin and skin lipid, and the influence of particle composition on drug distribution within the skin strata.
引用
收藏
页码:783 / 804
页数:22
相关论文
共 125 条
[21]   New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes [J].
Cevc, G ;
Blume, G .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2001, 1514 (02) :191-205
[22]  
Charles L, 2003, Cardiac glycosides for treating muscle pain and spasm, Patent No. [US20030229029, 20030229029]
[23]   Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles [J].
Cheow, Wean Sin ;
Hadinoto, Kunn .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 85 (02) :214-220
[24]   Development of a new delivery system consisting in "drug - in cyclodextrin - in nanostructured lipid carriers" for ketoprofen topical delivery [J].
Cirri, M. ;
Bragagni, M. ;
Mennini, N. ;
Mura, P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2012, 80 (01) :46-53
[25]  
Dancik Y., 2008, DERMAL ABSORPTION TO, P209, DOI 10.3109/9780849375927-16
[26]   Infectious Skin Diseases: A Review and Needs Assessment [J].
Dawson, Annelise L. ;
Dellavalle, Robert P. ;
Elston, Dirk M. .
DERMATOLOGIC CLINICS, 2012, 30 (01) :141-+
[27]  
Dima S, 2008, ROM BIOTECH LETT, V13, P49
[28]   Can drug-bearing liposomes penetrate intact skin? [J].
El Maghraby, GMM ;
Williams, AC ;
Barry, BW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2006, 58 (04) :415-429
[29]   Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro [J].
El Maghraby, GMM ;
Williams, AC ;
Barry, BW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (08) :1069-1077
[30]  
El Mahrab Robert., 2006, American Journal of Drug Delivery, V4, P231, DOI [10.2165/00137696-200604040-00006, DOI 10.2165/00137696-200604040-00006]